Management

Opto Circuits raises Rs 400 cr from QIP issue

Bangalore-based maker of medical diagnostic equipment, Opto Circuits (India) Limited has raised Rs 400 crore from qualified institutional buyers (QIBs). - ING Vysya Bank raises Rs 230 cr through QIP issue - Ackruti City QIP to open on Sept 3 - Jindal Cotex IPO subscribed 62% on third day - Prakash Industries to raise up to Rs 500 cr - HDFC: Cashing in at the right time - HDFC to raise over Rs 4,000 crore through QIBs The company"s QIP issue which opened on September 8 closed late evening on the same day following a huge response from QIBs. The company"s QIP committee had fixed Rs 186.63 as the floor price per equity share of Rs 10 each. The committee has authorised Vinod Ramnani, chairman and managing director, Opto Circuits, Jayesh Patel and Rajkumar Raisinghani, directors of the company to to inform the stock exchanges and filing of applications for seeking listing and trading permissions in respect of the shares from the stock exchanges.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
NMDC may get issue advisors, investment bankers soon
The government is likely to appoint investment bankers and advisors soon for the disinvestment of additional 8.38 per cent stake in iron ore producer NMDC, official sources said today.
Popular Articles
quick payday loans

Pratibha hits upper circuit on Rs 523cr order
Pratibha Industries zoomed 10% to close at its upper circuit limit of Rs 178. The counter witnessed a near five-fold increase in its total traded of 51,462 shares as against its two-week average traded quantity of 10,784 shares.

Sun Pharma gets USFDA nod for anti hypertensive drug
Sun Pharmaceutical Industries today said it has got the approval for its Abbreviated New Drug Application (ANDA) for the generic version of Quinapril Hydrochloride tablets used in the treatment of hypertension and congested heart failure.